임상

HOME > 연구실적 > 임상 > 논문
 
작성일 : 16-03-13 21:40
논문번호 45
논문제목(영문) Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries.
국내외구분 국외 SCI여부 SCI(E)
연구책임자역할 교신저자
주저자명 Hong YJ
교신저자명 Jeong MH
공동저자명 Hong YJ, Jeong MH, Kim W, Lim SY, Lee SH, Hong SN, Kim JH, Ahn YK, Cho JG, Park JC, Cho DL, Kim H, Kang JC;
게제년월일 2004-10-15
ISSN 0002-9149
Impact Factor 3.276
학술지명 The American journal of cardiology
서지사항 0집 / 94권 / 8호,   페이지(1050 - 1054)
요약초록문
(Abstract) 입력		 The investigators tested whether abciximab-coated stents prevent neointimal hyperplasia (NIH) formation in coronary de novo lesions. Abciximab-coated stents were compared with control stents. All patients underwent follow-up coronary angiography and intravascular ultrasound (IVUS). All stents were successfully deployed, and patients were discharged home without clinical events. At follow-up coronary angiography, the restenosis rate and late loss were 14% and 0.33 +/- 0.28 mm in the abciximab-coated stent group and 28.6% and 0.64 +/- 0.32 mm in the control stent group (p = 0.099 and p = 0.014, respectively). At follow-up IVUS, the intrastent luminal area and intrastent NIH area were 5.7 +/- 1.6 and 2.0 +/- 1.6 mm(2), respectively, in the abciximab-coated stent group and 4.2 +/- 0.8 and 3.4 +/- 1.7 mm(2), respectively, in the control stent group (p = 0.001 and p = 0.001, respectively). Abciximab-coated stents are feasible and significantly inhibit NIH, with potential therapeutic benefit in preventing stent restenosis.
파일  C45.+Am+J+Cardiol.+2004;94(8)1050-1054..pdf (270.2K) DATE : 2021-05-21 16:30:31